Skip to Content
Merck
CN
  • Biocompatibility and bioactivity of plasma-treated biodegradable poly(butylene succinate).

Biocompatibility and bioactivity of plasma-treated biodegradable poly(butylene succinate).

Acta biomaterialia (2008-09-02)
Huaiyu Wang, Junhui Ji, Wei Zhang, Yihe Zhang, Jiang Jiang, Zhengwei Wu, Shihao Pu, Paul K Chu
ABSTRACT

Poly(butylene succinate) (PBSu), a novel biodegradable aliphatic polyester with excellent processability and mechanical properties, is a promising substance for bone and cartilage repair. However, it typically suffers from insufficient biocompatibility and bioactivity after implantation into the human body. In this work, H(2)O or NH(3) plasma immersion ion implantation (PIII) is conducted for the first time to modify the PBSu surface. Both the treated and control specimens are characterized by X-ray photoelectron spectroscopy, contact angle measurements and atomic force microscopy. The plasma treatments improve the hydrophilicity and roughness of PBSu significantly and the different PIII processes result in similar hydrophilicity and topography. C-OH and C-NH(2) functional groups emerge on the PBSu surface after H(2)O and NH(3) PIII, respectively. The biological results demonstrate that both osteoblast compatibility and apatite formability are enhanced after H(2)O and NH(3) PIII. Furthermore, our results suggest that H(2)O PIII is more effective in rendering PBSu suitable for bone-replacement implants compared to NH(3) PIII.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Polybutenes, average Mn ~920 by VPO, isobutylene >90 %
Sigma-Aldrich
Polybutenes, average Mn ~2,300 by VPO, isobutylene >90 %